We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Maelor | LSE:MLR | London | Ordinary Share | GB00B2QBY649 | ORD 70P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 100.00 | 0.00 | 00:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 100.00 | GBX |
Maelor (MLR) Share Charts1 Year Maelor Chart |
|
1 Month Maelor Chart |
Intraday Maelor Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 28/5/2024 | 06:50 | 'Sir' CrazyCoops | 7 |
| 06/7/2017 | 14:42 | Maelor PLC - Niche healthcare innovations or just extracting the urine? | 1,707 |
| 09/11/2007 | 11:52 | MLR has been overlooked | 53 |
| 22/10/2007 | 16:50 | Patent News | 27 |
| 08/10/2007 | 14:30 | Maelor - New Thread | 21 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 12/4/2008 15:12 by gogoneko All I see is an absence of argument for the "huge premium" claim based on any fact, i.e. nobody has disputed that the 10x pro forma EBITDA payment is too much - which is what MLR have used for their valuation. Simply putting forward a bunch of assumptive "what if" cases relating to the competitor suddenly deciding to squeeze MLR out of certain markets should be reflected in a risk factor in the share price, not the amount MLR should have paid.More "what if"s: What if Ferring decides that the market is too small to defend or has bigger fish to fry? What if regulatory approval for Haemopressin isn't given? Why does the £2m milestone payment only relate to "certain products" approval in UK, France and Italy only? Was that year's EBITDA an anomaly?, etc, etc. We're only going to know over time whether the amount paid was too much or not but I think the company is turning its back on PIs so with that attitude I'm never going to hold long-term. As quite a few others are questioning director motives the shares could drop as investors lose confidence/interest even though the company currently has a profitable and growing business even though it'll still be settling payments 4-5 years hence. The danger has always been though that the company would overpay on expansion and at the first sign of things not going to plan then the shares will be hit - so far, from a performance perspective, the company have delivered. |
Posted at 11/4/2008 20:17 by waxman3 gogoneko - 31 Mar'08 - 14:38 - 1660 of 1669I'm not surprised that the share price isn't sinking that much as the company is increasingly looking in better shape with the addition of more profitable revenue streams and expanded markets. For Gawd's sake get wise and analys this latest scam and the products MLR has paid a huge premium for SEPI, SEPI competes with Ferring who have an almost identical product to Terlipressin under differnt branding and much larger market share. Ferring could swamp MLR or IS PHARMA plc, as it proposes name change to. So we have now 7 shares of 10p in Maelor consolidated into 1 new share of 70p I am wagering now, revising my estimate down, that it will settle around 50p Also take a look at this Talk about keeping it in th circle. Look as if the priavte shareholder has been shafted again. But then I did tell you all to sell some time back when I got wind of these things. And of course took your sh(t again over exposing dog shares. Tim may have been great as an employee of ELAN, but the hot seat is different and too date he has clearly demdisableded that its not an easy ride at the top.! |
Posted at 31/3/2008 13:38 by gogoneko I'm not surprised that the share price isn't sinking that much as the company is increasingly looking in better shape with the addition of more profitable revenue streams and expanded markets. The trouble is that I expect quite a few don't appreciate that a minority of players are increasingly taking the majority of the riches. The company in my opinion is moving forwards as a business but leaving private investors behind. I really am eager to see how those who've given Maelor recommendations in the press cover the issue of dilution and the closed community for cheap shares issues - I expect that they'll avoid those areas, blame the lack of increase in share price on the credit crunch, and suggest "keep buying"! |
Posted at 31/3/2008 11:26 by pheasant1 This stinks.5th April 2007, Maelor buys Acorus for £13.25m; Maelor NED Peter Murray is a major shareholder in Acorus. Deal funded by way of a highly dilutive private placing through Noble & Company; Maelor NED John Gregory is chairman of Noble VCT. 8th May 2007, Maelor board awards itself 8.4m options at 10 pence. 28th March 2008, Maelor announces that it intends to acquire SEPI AG for £14.25m; Maelor chairman Geoff McMillan is a major shareholder in SEPI. Deal to be funded by way of yet another highly dilutive private placing through Noble & Company, at a discount of more than 20% relative to share price on 27th March 2008; Maelor NED John Gregory is still chairman of Noble VCT. Why is it that Maelor is the only customer for Acorus and SEPI - both deadly dull clunkers with little future, IMHO. Why is it that the only funding route open to Maelor is private placings at substantial discounts to the current share price ? |
Posted at 28/3/2008 16:10 by steeplejack The placing discount at over 20% to yesterday's closing price is larger than you might have hoped but i'm sure the broker has done a bit of quiet enquiry to find out what an acceptable placing price for interested institutions would be. I reckon if you rang up Noble and told 'em you were a holder they'd cut you into the placing.MLR had a rights some years back at 25p from memory and it was near fully taken up.Thing is,rights issues are time-consuming and expensive,underwriti As far as the new management is concerned ,i'd guess they're keen to build a new institutional client base given the company's past track record and share price performance.Anyway,o |
Posted at 18/2/2008 14:32 by waxman3 The agguement is really quite simply.MLR still has a substantial private shareholder base, some still very loyal the the share price they bought in at, many up to two pounds a share. There was always a risk of institutional dumping when the new MLR was floated at 10p. I believe that substance could have been given to the floatation had the private investors been allowed a slice of the action. Private shareholder being as they are, really quite a loyal old bunch. You are now experiencing the proof of the pudding as the share price dirts no matter what the director do now. |
Posted at 11/2/2008 10:35 by waxman3 This is what I have been telling you all. The Accorus deal was a good deal but a bad deal for the small shareholder now faced with a massive overhang of cheap shares at 10pThe board of directors have behaved just like the old bord with no respect for their private holders. Hense the share price will suffer for amy a long year still, thanks why I sold out, and I aam alñready quids ahead with GDP. I WILL KEEP WATCHING MLR BUT JUST DID NOT WANT TO WAIT RIGHT NOW FOR A PROTRACT share price rise. If Tim's buying could not shift it then nothing well for a while, meanwhile its just like you local corner sweet shop a nice little business but going no where fast. |
Posted at 19/1/2008 11:42 by gogoneko I reckon any board or PR company would be wasting their time/money trying to push up the share price with no-news or bluster if there's a very big seller in the market. For the share price to move I reckon the solution is for the board to find a home for the shares which Liontrust don't want.If they're not doing this it'd imply that they're happy with the share price at today's levels, if they are doing this then it's a poor reflection on the company and board that there's no confidence in their ability (as the placing was oversubsribed at just 10p) and things have gone very well since then - performance that their predecesors never delivered. |
Posted at 11/12/2007 23:15 by gogoneko I hope that someone does approach MLR with a hostile bid at some nominal amount above today's share price to give management a boot up the backside. Previously I'd supported them for getting the support during the acquisition but I now reluctantly feel that they deserve to be undervalued for their assumed clumsiness in having given away big tranches on the cheap to weak holders.I cannot understand the actions of Liontrust - maybe there's a rule which says that it will be taxed punitively when the gains on investment exceed 40%. I also cannot believe that the management intended the share price to be trading at these levels after delivering an otherwise excellent performance to date. During the acquisition they clearly stated their intention to deliver shareholder value and so far that has failed to materialise as they have only delivered an increasing undervaluation - and to my knowledge that isn't what the investment community expects a company to achieve. At this rate we'll maybe have to wait for another 12 months before Liontrust have dumped the remaining 6m shares they hold for 14p so maybe by Jan 2009 we'll be leaving 15p behind! I also cannot figure out why another institution doesn't step forward to buy the remaining shares of Liontrust. Hmm, rant over! |
Posted at 30/8/2007 13:37 by 1ch gogoneko - agree - one very good set of results does not build a summer.However 'if' the same increase in turnover occurs this year as it did last year then as the preacher said people could begin to have faith, and faith could mean a better valuaion and share price. Remember though last year had they not just turned around into a small profit, so another good performance and who knows. The share price is again is creeping up - 1/2p today. Remember if my memory serves me rightly AMS is on a pe of 20, but with MLR there are no forecasted eps or turnover figures. If there is please post them. And 'if' the turnover again increases by was it 52% then we could see the share price nearer piruxi 50p target, although I would then say true valuation would be 39p. But first we need a second summer, and more so any increase in turnover of 52%, which may or may not be difficult to achieve. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
